speb/financial-data huggingface dataset:
EMR income_statement (quarterly, 2025-03-31) — EBITDA: 1099000000.00
EMR income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 0.00
EMR cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 25000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 453000000.00
EMR cash_flow (quarterly, 2025-03-31) — End Cash Position: 1887000000.00
EMR cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -1091000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Finished Goods: 527000000.00
EMR cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 154000000.00
EMR income_statement (quarterly, 2025-03-31) — Gain On Sale Of Business: 0.00
EMR income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -41000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -1150000000.00
EMR income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1283000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Goodwill: 17999000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 27822000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 3025000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Gross PPE: 6158000000.00
EMR income_statement (quarterly, 2025-03-31) — Gross Profit: 2371000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 150000000.00
EMR income_statement (quarterly, 2025-03-31) — Interest Expense: 86000000.00
EMR income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 86000000.00
EMR income_statement (quarterly, 2025-03-31) — Interest Income: 45000000.00
EMR income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 45000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Inventory: 2216000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Invested Capital: 33463000000.00
EMR cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -122000000.00
EMR cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 6666000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 488000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 8176000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 8664000000.00
EMR cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
EMR balance_sheet (quarterly, 2025-03-31) — Minority Interest: 17000000.00
EMR income_statement (quarterly, 2025-03-31) — Minority Interests: 55000000.00
EMR cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 1000000.00
EMR cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -223000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Net Debt: 12327000000.00
EMR income_statement (quarterly, 2025-03-31) — Net Income: 485000000.00
EMR income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 485000000.00
EMR income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 430000000.00
EMR income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: 0.00
EMR income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 485000000.00
EMR income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 485000000.00
EMR cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 429000000.00
EMR income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 430000000.00
EMR income_statement (quarterly, 2025-03-31) — Net Interest Income: -41000000.00
EMR cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 6666000000.00
EMR cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 1544000000.00
EMR income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -41000000.00
EMR cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -7237000000.00
EMR cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -36000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Net PPE: 2757000000.00
EMR cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 5122000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -8573000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 2012000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2012000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 453000000.00
EMR income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 1305000000.00
EMR income_statement (quarterly, 2025-03-31) — Normalized Income: 625826709.06
EMR cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 241000000.00
EMR income_statement (quarterly, 2025-03-31) — Operating Income: 859000000.00
EMR income_statement (quarterly, 2025-03-31) — Operating Revenue: 4432000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 562500000.00
EMR balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1623000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 6038000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 149000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -1150000000.00
EMR income_statement (quarterly, 2025-03-31) — Other Gand A: 1283000000.00
EMR income_statement (quarterly, 2025-03-31) — Other Income Expense: -189000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 9823000000.00
EMR cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 3000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 2772000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 737000000.00
EMR income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 17000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Payables: 1490000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 2753000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 561000000.00
EMR income_statement (quarterly, 2025-03-31) — Pretax Income: 629000000.00
EMR cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 1000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Raw Materials: 1689000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Receivables: 2901000000.00
EMR income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1906000000.00
EMR income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 384000000.00
EMR cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
EMR cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -223000000.00
EMR income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 165000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 39977000000.00
EMR income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1283000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Share Issued: 953400000.00
EMR cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 5122000000.00
EMR cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: 0.00
EMR income_statement (quarterly, 2025-03-31) — Special Income Charges: -165000000.00
EMR cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 59000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 19249000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -8573000000.00
EMR income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -65173290.94
EMR income_statement (quarterly, 2025-03-31) — Tax Provision: 199000000.00
EMR income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.32
EMR balance_sheet (quarterly, 2025-03-31) — Total Assets: 41978000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 27425000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Total Debt: 14851000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 19266000000.00
EMR income_statement (quarterly, 2025-03-31) — Total Expenses: 3573000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 22712000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 33351000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 11866000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 150000000.00
EMR income_statement (quarterly, 2025-03-31) — Total Unusual Items: -206000000.00
EMR income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -206000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 390900000.00
EMR balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 20055000000.00
EMR balance_sheet (quarterly, 2025-03-31) — Working Capital: -2219000000.00
EMR income_statement (quarterly, 2025-06-30) — +Operating Expense: 1485000000.00
EMR income_statement (quarterly, 2025-06-30) — +Total Revenue: 4553000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1272000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 2908000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -3480000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 28000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -125000000.00
EMR income_statement (quarterly, 2025-06-30) — Amortization: 219000000.00
EMR cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 292000000.00
EMR cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 292000000.00
EMR income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 219000000.00
EMR income_statement (quarterly, 2025-06-30) — Basic Average Shares: 562100000.00
EMR income_statement (quarterly, 2025-06-30) — Basic EPS: 1.04
EMR cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1887000000.00
EMR cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -93000000.00
EMR cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -93000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 638000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Capital Stock: 477000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 2219000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 2219000000.00
EMR cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -297000000.00
EMR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -637000000.00
EMR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -129000000.00
EMR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 1061000000.00
EMR cash_flow (quarterly, 2025-06-30) — Cash From Discontinued Investing Activities: 0.00
EMR cash_flow (quarterly, 2025-06-30) — Cash From Discontinued Operating Activities: 9000000.00
EMR cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -27000000.00
EMR cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 151000000.00
EMR cash_flow (quarterly, 2025-06-30) — Change In Inventory: -24000000.00
EMR cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -21000000.00
EMR cash_flow (quarterly, 2025-06-30) — Change In Payable: -27000000.00
EMR cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 124000000.00
EMR cash_flow (quarterly, 2025-06-30) — Change In Receivables: 44000000.00
EMR cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 123000000.00
EMR cash_flow (quarterly, 2025-06-30) — Changes In Cash: 304000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Common Stock: 477000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 19870000000.00
EMR cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -25000000.00
EMR income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2160000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1460000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Current Assets: 9072000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 150000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Current Debt: 5953000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 6103000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 1125000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 1125000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 10732000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Current Provisions: 88000000.00
EMR cash_flow (quarterly, 2025-06-30) — Depreciation: 80000000.00
EMR cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 372000000.00
EMR income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 219000000.00
EMR cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 372000000.00
EMR income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 219000000.00
EMR income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 564700000.00
EMR income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.04
EMR income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 586000000.00
EMR income_statement (quarterly, 2025-06-30) — EBIT: 829000000.00
EMR income_statement (quarterly, 2025-06-30) — EBITDA: 1201000000.00
EMR income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 0.00
EMR cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 28000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 464000000.00
EMR cash_flow (quarterly, 2025-06-30) — End Cash Position: 2219000000.00
EMR cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -637000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Finished Goods: 553000000.00
EMR cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 977000000.00
EMR cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of Business: 0.00
EMR income_statement (quarterly, 2025-06-30) — Gain On Sale Of Business: 0.00
EMR income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -31000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -850000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Goodwill: 18158000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 27827000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 3033000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Gross PPE: 6271000000.00
EMR income_statement (quarterly, 2025-06-30) — Gross Profit: 2393000000.00
EMR income_statement (quarterly, 2025-06-30) — Interest Expense: 95000000.00
EMR income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 95000000.00
EMR income_statement (quarterly, 2025-06-30) — Interest Income: 0.00
EMR income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 0.00
EMR balance_sheet (quarterly, 2025-06-30) — Inventory: 2288000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Invested Capital: 34101000000.00
EMR cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -129000000.00
EMR cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 1587000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 488000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 8278000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 8766000000.00
EMR cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
EMR cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -501000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Minority Interest: 16000000.00
EMR income_statement (quarterly, 2025-06-30) — Minority Interests: 0.00
EMR cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
EMR cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -25000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Net Debt: 12012000000.00
EMR income_statement (quarterly, 2025-06-30) — Net Income: 586000000.00
EMR income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 586000000.00
EMR income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 580000000.00
EMR income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 6000000.00
EMR income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 586000000.00
EMR income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 580000000.00
EMR cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 580000000.00
EMR income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 586000000.00
EMR income_statement (quarterly, 2025-06-30) — Net Interest Income: -95000000.00
EMR cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -263000000.00
EMR cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -501000000.00
EMR income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -95000000.00
EMR cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -52000000.00
EMR cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -36000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Net PPE: 2791000000.00
EMR cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 238000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -7957000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 1914000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 1914000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 464000000.00
EMR income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 1294000000.00
EMR income_statement (quarterly, 2025-06-30) — Normalized Income: 653470000.00
EMR cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 1070000000.00
EMR income_statement (quarterly, 2025-06-30) — Operating Income: 908000000.00
EMR income_statement (quarterly, 2025-06-30) — Operating Revenue: 4553000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 562800000.00
EMR balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1657000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 5953000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -850000000.00
EMR income_statement (quarterly, 2025-06-30) — Other Income Expense: -79000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 9669000000.00
EMR cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -85000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 2827000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 755000000.00
EMR income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 14000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Payables: 1272000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 2732000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 684000000.00
EMR income_statement (quarterly, 2025-06-30) — Pretax Income: 734000000.00
EMR cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
EMR balance_sheet (quarterly, 2025-06-30) — Raw Materials: 1735000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Receivables: 2908000000.00
EMR income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2007000000.00
EMR income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 372000000.00
EMR cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1850000000.00
EMR cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -25000000.00
EMR income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 62000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 40265000000.00
EMR cash_flow (quarterly, 2025-06-30) — Sale Of Business: 0.00
EMR income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1266000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Share Issued: 946000000.00
EMR cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 1587000000.00
EMR cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: -1349000000.00
EMR income_statement (quarterly, 2025-06-30) — Special Income Charges: -62000000.00
EMR cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 71000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 19870000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -7957000000.00
EMR income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -19530000.00
EMR income_statement (quarterly, 2025-06-30) — Tax Provision: 154000000.00
EMR income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
EMR balance_sheet (quarterly, 2025-06-30) — Total Assets: 42517000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 28148000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Total Debt: 14869000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 19886000000.00
EMR income_statement (quarterly, 2025-06-30) — Total Expenses: 3645000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 22631000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 33445000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 11899000000.00
EMR income_statement (quarterly, 2025-06-30) — Total Unusual Items: -93000000.00
EMR income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -93000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 383200000.00
EMR balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 20050000000.00
EMR balance_sheet (quarterly, 2025-06-30) — Working Capital: -1660000000.00
EMR income_statement (annual, 2025-09-30) — +Operating Expense: 5987000000.00
EMR income_statement (quarterly, 2025-09-30) — +Operating Expense: 1537000000.00
EMR income_statement (annual, 2025-09-30) — +Total Revenue: 18016000000.00
EMR income_statement (quarterly, 2025-09-30) — +Total Revenue: 4855000000.00
EMR balance_sheet (annual, 2025-09-30) — Accounts Payable: 1384000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1384000000.00
EMR balance_sheet (annual, 2025-09-30) — Accounts Receivable: 3101000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 3101000000.00
EMR balance_sheet (annual, 2025-09-30) — Accumulated Depreciation: -3537000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -3537000000.00
EMR balance_sheet (annual, 2025-09-30) — Additional Paid In Capital: 85000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 85000000.00
EMR balance_sheet (annual, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -123000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -123000000.00
EMR income_statement (annual, 2025-09-30) — Amortization: 884000000.00
EMR income_statement (quarterly, 2025-09-30) — Amortization: 207000000.00
EMR cash_flow (annual, 2025-09-30) — Amortization Cash Flow: 1174000000.00
EMR cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 281000000.00
EMR cash_flow (annual, 2025-09-30) — Amortization Of Intangibles: 1174000000.00
EMR cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 281000000.00
EMR income_statement (annual, 2025-09-30) — Amortization Of Intangibles Income Statement: 884000000.00
EMR income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 207000000.00
EMR income_statement (annual, 2025-09-30) — Basic Average Shares: 562800000.00
EMR income_statement (quarterly, 2025-09-30) — Basic Average Shares: 562800000.00
EMR income_statement (annual, 2025-09-30) — Basic EPS: 4.07
EMR income_statement (quarterly, 2025-09-30) — Basic EPS: 1.13
EMR cash_flow (annual, 2025-09-30) — Beginning Cash Position: 3588000000.00
EMR cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 2219000000.00
EMR balance_sheet (annual, 2025-09-30) — Buildings And Improvements: 2127000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 2127000000.00
EMR cash_flow (annual, 2025-09-30) — Capital Expenditure: -431000000.00
EMR cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -168000000.00
EMR cash_flow (annual, 2025-09-30) — Capital Expenditure Reported: -431000000.00
EMR cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -168000000.00
EMR balance_sheet (annual, 2025-09-30) — Capital Lease Obligations: 643000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 643000000.00
EMR balance_sheet (annual, 2025-09-30) — Capital Stock: 477000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Capital Stock: 477000000.00
EMR balance_sheet (annual, 2025-09-30) — Cash And Cash Equivalents: 1544000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1544000000.00
EMR balance_sheet (annual, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1544000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1544000000.00
EMR cash_flow (annual, 2025-09-30) — Cash Dividends Paid: -1192000000.00
EMR cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -297000000.00
EMR cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Financing Activities: -4510000000.00
EMR cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -1491000000.00
EMR cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Investing Activities: -593000000.00
EMR cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -200000000.00
EMR cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Operating Activities: 3676000000.00
EMR cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 1012000000.00
EMR cash_flow (annual, 2025-09-30) — Cash From Discontinued Investing Activities: 0.00
EMR cash_flow (quarterly, 2025-09-30) — Cash From Discontinued Investing Activities: 0.00
EMR cash_flow (annual, 2025-09-30) — Cash From Discontinued Operating Activities: -578000000.00
EMR cash_flow (quarterly, 2025-09-30) — Cash From Discontinued Operating Activities: -2000000.00
EMR cash_flow (annual, 2025-09-30) — Change In Account Payable: 34000000.00
EMR cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 96000000.00
EMR cash_flow (annual, 2025-09-30) — Change In Accrued Expense: 281000000.00
EMR cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 114000000.00
EMR cash_flow (annual, 2025-09-30) — Change In Inventory: -1000000.00
EMR cash_flow (quarterly, 2025-09-30) — Change In Inventory: 90000000.00
EMR cash_flow (annual, 2025-09-30) — Change In Other Current Assets: -152000000.00
EMR cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -39000000.00
EMR cash_flow (annual, 2025-09-30) — Change In Payable: 34000000.00
EMR cash_flow (quarterly, 2025-09-30) — Change In Payable: 96000000.00
EMR cash_flow (annual, 2025-09-30) — Change In Payables And Accrued Expense: 315000000.00
EMR cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 210000000.00
EMR cash_flow (annual, 2025-09-30) — Change In Receivables: -171000000.00
EMR cash_flow (quarterly, 2025-09-30) — Change In Receivables: -190000000.00
EMR cash_flow (annual, 2025-09-30) — Change In Working Capital: -9000000.00
EMR cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 71000000.00
EMR cash_flow (annual, 2025-09-30) — Changes In Cash: -2005000000.00
EMR cash_flow (quarterly, 2025-09-30) — Changes In Cash: -681000000.00
EMR balance_sheet (annual, 2025-09-30) — Common Stock: 477000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Common Stock: 477000000.00
EMR cash_flow (annual, 2025-09-30) — Common Stock Dividend Paid: -1192000000.00
EMR balance_sheet (annual, 2025-09-30) — Common Stock Equity: 20282000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 20282000000.00
EMR cash_flow (annual, 2025-09-30) — Common Stock Payments: -1167000000.00
EMR cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -20000000.00
EMR balance_sheet (annual, 2025-09-30) — Construction In Progress: 314000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 314000000.00
EMR income_statement (annual, 2025-09-30) — Cost Of Revenue: 8497000000.00
EMR income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2336000000.00
EMR balance_sheet (annual, 2025-09-30) — Current Accrued Expenses: 1487000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 1487000000.00
EMR balance_sheet (annual, 2025-09-30) — Current Assets: 8583000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Current Assets: 8583000000.00
EMR balance_sheet (annual, 2025-09-30) — Current Capital Lease Obligation: 138000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 138000000.00
EMR balance_sheet (annual, 2025-09-30) — Current Debt: 4797000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Current Debt: 4797000000.00
EMR balance_sheet (annual, 2025-09-30) — Current Debt And Capital Lease Obligation: 4935000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 4935000000.00
EMR balance_sheet (annual, 2025-09-30) — Current Deferred Liabilities: 1031000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 1031000000.00
EMR balance_sheet (annual, 2025-09-30) — Current Deferred Revenue: 1031000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 1031000000.00
EMR balance_sheet (annual, 2025-09-30) — Current Liabilities: 9797000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 9797000000.00
EMR balance_sheet (annual, 2025-09-30) — Current Provisions: 90000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Current Provisions: 90000000.00
EMR balance_sheet (annual, 2025-09-30) — Defined Pension Benefit: 1229000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Defined Pension Benefit: 1229000000.00
EMR cash_flow (annual, 2025-09-30) — Depreciation: 344000000.00
EMR cash_flow (quarterly, 2025-09-30) — Depreciation: 98000000.00
EMR cash_flow (annual, 2025-09-30) — Depreciation Amortization Depletion: 1518000000.00
EMR cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 379000000.00
EMR income_statement (annual, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 884000000.00
EMR income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 207000000.00
EMR cash_flow (annual, 2025-09-30) — Depreciation And Amortization: 1518000000.00
EMR cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 379000000.00
EMR income_statement (annual, 2025-09-30) — Depreciation And Amortization In Income Statement: 884000000.00
EMR income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 207000000.00
EMR income_statement (annual, 2025-09-30) — Diluted Average Shares: 566700000.00
EMR income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 565500000.00
EMR income_statement (annual, 2025-09-30) — Diluted EPS: 4.04
EMR income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.12
EMR income_statement (annual, 2025-09-30) — Diluted NI Availto Com Stockholders: 2293000000.00
EMR income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 636000000.00
EMR income_statement (annual, 2025-09-30) — EBIT: 3321000000.00
EMR income_statement (quarterly, 2025-09-30) — EBIT: 1038000000.00
EMR income_statement (annual, 2025-09-30) — EBITDA: 4839000000.00
EMR income_statement (quarterly, 2025-09-30) — EBITDA: 1417000000.00
EMR income_statement (annual, 2025-09-30) — Earnings From Equity Interest: 0.00
EMR income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 0.00
EMR cash_flow (annual, 2025-09-30) — Effect Of Exchange Rate Changes: -39000000.00
EMR cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 6000000.00
EMR balance_sheet (annual, 2025-09-30) — Employee Benefits: 467000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 467000000.00
EMR cash_flow (annual, 2025-09-30) — End Cash Position: 1544000000.00
EMR cash_flow (quarterly, 2025-09-30) — End Cash Position: 1544000000.00
EMR cash_flow (annual, 2025-09-30) — Financing Cash Flow: -4510000000.00
EMR cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -1491000000.00
EMR balance_sheet (annual, 2025-09-30) — Finished Goods: 520000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Finished Goods: 520000000.00
EMR cash_flow (annual, 2025-09-30) — Free Cash Flow: 2667000000.00
EMR cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 842000000.00
EMR income_statement (annual, 2025-09-30) — Gain On Sale Of Business: 0.00
EMR income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: 0.00
EMR income_statement (annual, 2025-09-30) — Gain On Sale Of Security: -92000000.00
EMR income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -19000000.00
EMR balance_sheet (annual, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -821000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -821000000.00
EMR income_statement (annual, 2025-09-30) — General And Administrative Expense: 5103000000.00
EMR balance_sheet (annual, 2025-09-30) — Goodwill: 18193000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Goodwill: 18193000000.00
EMR balance_sheet (annual, 2025-09-30) — Goodwill And Other Intangible Assets: 27651000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 27651000000.00
EMR balance_sheet (annual, 2025-09-30) — Gross Accounts Receivable: 3224000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 3224000000.00
EMR balance_sheet (annual, 2025-09-30) — Gross PPE: 7045000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Gross PPE: 7045000000.00
EMR income_statement (annual, 2025-09-30) — Gross Profit: 9519000000.00
EMR income_statement (quarterly, 2025-09-30) — Gross Profit: 2519000000.00
EMR balance_sheet (annual, 2025-09-30) — Income Tax Payable: 130000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 130000000.00
EMR income_statement (annual, 2025-09-30) — Interest Expense: 387000000.00
EMR income_statement (quarterly, 2025-09-30) — Interest Expense: 242000000.00
EMR income_statement (annual, 2025-09-30) — Interest Expense Non Operating: 387000000.00
EMR income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 242000000.00
EMR income_statement (annual, 2025-09-30) — Interest Income: 150000000.00
EMR income_statement (quarterly, 2025-09-30) — Interest Income: 150000000.00
EMR income_statement (annual, 2025-09-30) — Interest Income Non Operating: 150000000.00
EMR income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 150000000.00
EMR balance_sheet (annual, 2025-09-30) — Inventory: 2213000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Inventory: 2213000000.00
EMR balance_sheet (annual, 2025-09-30) — Invested Capital: 33398000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Invested Capital: 33398000000.00
EMR cash_flow (annual, 2025-09-30) — Investing Cash Flow: -593000000.00
EMR cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -200000000.00
EMR cash_flow (annual, 2025-09-30) — Issuance Of Debt: 10662000000.00
EMR cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 2407000000.00
EMR balance_sheet (annual, 2025-09-30) — Land And Improvements: 273000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 273000000.00
EMR balance_sheet (annual, 2025-09-30) — Long Term Capital Lease Obligation: 505000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 505000000.00
EMR balance_sheet (annual, 2025-09-30) — Long Term Debt: 8319000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 8319000000.00
EMR balance_sheet (annual, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 8824000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 8824000000.00
EMR cash_flow (annual, 2025-09-30) — Long Term Debt Issuance: 1544000000.00
EMR cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
EMR cash_flow (annual, 2025-09-30) — Long Term Debt Payments: -503000000.00
EMR cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
EMR balance_sheet (annual, 2025-09-30) — Machinery Furniture Equipment: 3694000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 3694000000.00
EMR balance_sheet (annual, 2025-09-30) — Minority Interest: 16000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Minority Interest: 16000000.00
EMR income_statement (annual, 2025-09-30) — Minority Interests: 47000000.00
EMR income_statement (quarterly, 2025-09-30) — Minority Interests: -1000000.00
EMR cash_flow (annual, 2025-09-30) — Net Business Purchase And Sale: -37000000.00
EMR cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -1000000.00
EMR cash_flow (annual, 2025-09-30) — Net Common Stock Issuance: -1167000000.00
EMR cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -20000000.00
EMR balance_sheet (annual, 2025-09-30) — Net Debt: 11572000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Net Debt: 11572000000.00
EMR income_statement (annual, 2025-09-30) — Net Income: 2293000000.00
EMR income_statement (quarterly, 2025-09-30) — Net Income: 636000000.00
EMR income_statement (annual, 2025-09-30) — Net Income Common Stockholders: 2293000000.00
EMR income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 636000000.00
EMR income_statement (annual, 2025-09-30) — Net Income Continuous Operations: 2238000000.00
EMR income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 636000000.00
EMR income_statement (annual, 2025-09-30) — Net Income Discontinuous Operations: 8000000.00
EMR income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 1000000.00
EMR income_statement (annual, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 2293000000.00
EMR income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 636000000.00
EMR income_statement (annual, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 2285000000.00
EMR income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 635000000.00
EMR cash_flow (annual, 2025-09-30) — Net Income From Continuing Operations: 2238000000.00
EMR cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 636000000.00
EMR income_statement (annual, 2025-09-30) — Net Income Including Noncontrolling Interests: 2246000000.00
EMR income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 637000000.00
EMR income_statement (annual, 2025-09-30) — Net Interest Income: -237000000.00
EMR income_statement (quarterly, 2025-09-30) — Net Interest Income: -92000000.00
EMR cash_flow (annual, 2025-09-30) — Net Issuance Payments Of Debt: 5241000000.00
EMR cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -1162000000.00
EMR cash_flow (annual, 2025-09-30) — Net Long Term Debt Issuance: 1041000000.00
EMR cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
EMR income_statement (annual, 2025-09-30) — Net Non Operating Interest Income Expense: -237000000.00
EMR income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -92000000.00
EMR cash_flow (annual, 2025-09-30) — Net Other Financing Charges: -7392000000.00
EMR cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -12000000.00
EMR cash_flow (annual, 2025-09-30) — Net Other Investing Changes: -125000000.00
EMR cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -31000000.00
EMR balance_sheet (annual, 2025-09-30) — Net PPE: 3508000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Net PPE: 3508000000.00
EMR cash_flow (annual, 2025-09-30) — Net Short Term Debt Issuance: 4200000000.00
EMR cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -1162000000.00
EMR balance_sheet (annual, 2025-09-30) — Net Tangible Assets: -7369000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -7369000000.00
EMR balance_sheet (annual, 2025-09-30) — Non Current Accounts Receivable: 676000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 676000000.00
EMR balance_sheet (annual, 2025-09-30) — Non Current Deferred Assets: 79000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 79000000.00
EMR balance_sheet (annual, 2025-09-30) — Non Current Deferred Liabilities: 1822000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 1822000000.00
EMR balance_sheet (annual, 2025-09-30) — Non Current Deferred Taxes Assets: 79000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 79000000.00
EMR balance_sheet (annual, 2025-09-30) — Non Current Deferred Taxes Liabilities: 1822000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 1822000000.00
EMR balance_sheet (annual, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 467000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 467000000.00
EMR income_statement (annual, 2025-09-30) — Normalized EBITDA: 5281000000.00
EMR income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 1535000000.00
EMR income_statement (annual, 2025-09-30) — Normalized Income: 2622246000.00
EMR income_statement (quarterly, 2025-09-30) — Normalized Income: 729281407.04
EMR cash_flow (annual, 2025-09-30) — Operating Cash Flow: 3098000000.00
EMR cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 1010000000.00
EMR cash_flow (annual, 2025-09-30) — Operating Gains Losses: -58000000.00
EMR income_statement (annual, 2025-09-30) — Operating Income: 3532000000.00
EMR income_statement (quarterly, 2025-09-30) — Operating Income: 982000000.00
EMR income_statement (annual, 2025-09-30) — Operating Revenue: 18016000000.00
EMR income_statement (quarterly, 2025-09-30) — Operating Revenue: 4855000000.00
EMR balance_sheet (annual, 2025-09-30) — Ordinary Shares Number: 562800000.00
EMR balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 562800000.00
EMR balance_sheet (annual, 2025-09-30) — Other Current Assets: 1725000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1725000000.00
EMR balance_sheet (annual, 2025-09-30) — Other Current Borrowings: 4797000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 4797000000.00
EMR balance_sheet (annual, 2025-09-30) — Other Equity Adjustments: -821000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -821000000.00
EMR income_statement (annual, 2025-09-30) — Other Gand A: 5103000000.00
EMR income_statement (annual, 2025-09-30) — Other Income Expense: -361000000.00
EMR income_statement (quarterly, 2025-09-30) — Other Income Expense: -94000000.00
EMR balance_sheet (annual, 2025-09-30) — Other Intangible Assets: 9458000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 9458000000.00
EMR cash_flow (annual, 2025-09-30) — Other Non Cash Items: -276000000.00
EMR cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -81000000.00
EMR balance_sheet (annual, 2025-09-30) — Other Non Current Assets: 238000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 238000000.00
EMR balance_sheet (annual, 2025-09-30) — Other Non Current Liabilities: 756000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 756000000.00
EMR income_statement (annual, 2025-09-30) — Other Non Operating Income Expenses: 81000000.00
EMR income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 24000000.00
EMR balance_sheet (annual, 2025-09-30) — Other Properties: 637000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Other Properties: 637000000.00
EMR balance_sheet (annual, 2025-09-30) — Payables: 1514000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Payables: 1514000000.00
EMR balance_sheet (annual, 2025-09-30) — Payables And Accrued Expenses: 3001000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 3001000000.00
EMR cash_flow (annual, 2025-09-30) — Pension And Employee Benefit Expense: -58000000.00
EMR balance_sheet (annual, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 740000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 740000000.00
EMR income_statement (annual, 2025-09-30) — Pretax Income: 2934000000.00
EMR income_statement (quarterly, 2025-09-30) — Pretax Income: 796000000.00
EMR balance_sheet (annual, 2025-09-30) — Properties: 0.00
EMR balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
EMR cash_flow (annual, 2025-09-30) — Purchase Of Business: -37000000.00
EMR cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -1000000.00
EMR balance_sheet (annual, 2025-09-30) — Raw Materials: 1693000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Raw Materials: 1693000000.00
EMR balance_sheet (annual, 2025-09-30) — Receivables: 3101000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Receivables: 3101000000.00
EMR income_statement (annual, 2025-09-30) — Reconciled Cost Of Revenue: 7863000000.00
EMR income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2164000000.00
EMR income_statement (annual, 2025-09-30) — Reconciled Depreciation: 1518000000.00
EMR income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 379000000.00
EMR cash_flow (annual, 2025-09-30) — Repayment Of Debt: -5421000000.00
EMR cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -3569000000.00
EMR cash_flow (annual, 2025-09-30) — Repurchase Of Capital Stock: -1167000000.00
EMR cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -20000000.00
EMR income_statement (annual, 2025-09-30) — Restructuring And Mergern Acquisition: 350000000.00
EMR income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 99000000.00
EMR balance_sheet (annual, 2025-09-30) — Retained Earnings: 40603000000.00
EMR balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 40603000000.00
EMR cash_flow (annual, 2025-09-30) — Sale Of Business: 0.00
EMR cash_flow (quarterly, 2025-09-30) — Sale Of Business: 0.00
EMR income_statement (annual, 2025-09-30) — Selling General And Administration: 5103000000.00
EMR income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1330000000.00
EMR balance_sheet (annual, 2025-09-30) — Share Issued: 953400000.00
EMR balance_sheet (quarterly, 2025-09-30) — Share Issued: 953400000.00
EMR cash_flow (annual, 2025-09-30) — Short Term Debt Issuance: 9118000000.00
EMR cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 2407000000.00
EMR cash_flow (annual, 2025-09-30) — Short Term Debt Payments: -4918000000.00
EMR cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: -3569000000.00
EMR income_statement (annual, 2025-09-30) — Special Income Charges: -350000000.00
EMR income_statement (quarterly, 2025-09-30) — Special Income Charges: -99000000.00
EMR cash_flow (annual, 2025-09-30) — Stock Based Compensation: 263000000.00
EMR cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 65000000.00
EMR balance_sheet (annual, 2025-09-30) — Stockholders Equity: 20282000000.00